Owkin

French-American startup focused on utilizing AI and machine learning to enhance drug discovery and patient outcomes through the analysis of medical data. The company is distinguished by its federated learning approach, which allows for secure and collaborative data analysis across hospitals, research institutions, and pharmaceutical companies without sharing sensitive data. Owkin primarily serves the healthcare sector, including medical researchers, pharmaceutical companies, and healthcare providers seeking innovative solutions for drug development and patient care.

Owkin was discovered on November 11th 2024 and it currently has a search volume of 9.9K with a growth of +285%.